Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-21 Purchase | 2026-08-24 1:20 pm | Protagenic Therapeutics Inc. | PTIX | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | 20,000 | $0.65 | $13,000 | 73,533 (Direct) | View |
| 2026-08-20 Purchase | 2026-08-20 8:20 pm | Protagenic Therapeutics Inc. | PTIX | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | 16,634 | $0.5898 | $9,811 | 53,533 (Direct) | View |
| 2026-08-19 Purchase | 2026-08-20 09:23 am | Protagenic Therapeutics Inc. | PTIX | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | 2,700 | $0.35 | $945 | 36,899 (Direct) | View |
| 2026-08-11 Purchase | 2026-08-12 6:51 pm | Protagenic Therapeutics Inc. | PTIX | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | 2,220 | $0.32 | $710 | 34,199 (Direct) | View |
| 2026-08-06 Purchase | 2026-08-10 10:17 am | Protagenic Therapeutics Inc. | PTIX | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | 685 | $0.22 | $151 | 31,979 (Direct) | View |
| 2026-08-05 Purchase | 2026-08-06 8:29 pm | Protagenic Therapeutics Inc. | PTIX | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | 5,000 | $0.2588 | $1,294 | 31,294 (Direct) | View |
| 2026-07-30 Purchase | 2026-08-03 5:29 pm | Protagenic Therapeutics Inc. | PTIX | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF. | 26,291 | $0.1828 | $4,806 | 26,291 (Direct) | View |
| 2023-10-12 Purchase | 2023-10-13 12:48 pm | Protagenic Therapeutics Inc. | PTIX | Arrow Alexander K. Chief Financial Officer | 8,000 | $0.81 | $6,480 | 45,815 (Direct) | View |
| 2022-05-17 Purchase | 2022-05-18 5:11 pm | Protagenic Therapeutics Inc. | PTIX | Arrow Alexander K. Chief Financial Officer | 31,000 | $0.71258 | $22,090 | 151,260 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-10-24 1:40 pm | N/A N/A | Protagenic Therapeutics Inc. | PTIX | EVANS BARRETT EMC2 Capital LLC Mammoth Crest Capital LLC ex CEO 10% Owner | 0 | $0 | 154,552 (Indirect) | View |
| 2024-03-25 Option Award | 2024-04-01 9:41 pm | 2026-03-25 2034-03-25 | Protagenic Therapeutics Inc. | PTIX | WRIGHT TIMOTHY R Director | 21,250 | $1.74 | 21,250 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-29 9:29 pm | N/A 2034-03-25 | Protagenic Therapeutics Inc. | PTIX | Stein Robert Benjamin Director | 75,000 | $1.74 | 75,000 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-29 9:29 pm | 2026-03-25 2034-03-25 | Protagenic Therapeutics Inc. | PTIX | Barrage Khalil Director | 22,500 | $1.74 | 22,500 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-29 9:29 pm | N/A 2034-03-25 | Protagenic Therapeutics Inc. | PTIX | Buell Jennifer Director | 75,000 | $1.74 | 75,000 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-29 9:29 pm | 2027-03-25 2034-03-25 | Protagenic Therapeutics Inc. | PTIX | ARMEN GARO H Executive Chairman 10% Owner | 250,000 | $1.74 | 250,000 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-29 9:29 pm | 2026-03-25 2034-03-25 | Protagenic Therapeutics Inc. | PTIX | Corvese Brian Director | 43,750 | $1.74 | 43,750 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-29 9:29 pm | 2027-03-25 2034-03-25 | Protagenic Therapeutics Inc. | PTIX | Arrow Alexander K. Chief Financial Officer | 100,000 | $1.74 | 100,000 (Direct) | View |